Sarcoidosis juvenil: tratamiento con metotrexato
Molina, José Fernando; Gedalia, Abraham; Ellis, George; Galen, Wesley; Moore, Cleveland; Espinoza, Luis.
Rev. colomb. reumatol
; 4(4): 159-63, dic. 1997. tab
Artículo en Español | LILACS | ID: lil-293732
Documentos relacionados
Sarcoidosis with musculoskeletal manifestations: systematic review of non-pharmacological and pharmacological treatments.
Methotrexate for cardiac sarcoidosis: is it justifiable?
Methotrexate for Cutaneous Sarcoidosis: A Dermatology-Based Case Series of 23 Patients.
Efficacy of low-dose methotrexate in a short-regimen for granulomatous sarcoid-like reaction on permanent make-up during COVID-19 infection.
Clinical phenotypes and therapeutic responses in cutaneous-predominant sarcoidosis: 6-year experience in a tertiary referral service.
Treatment of Sarcoidosis.
Reply: A suggested classification of disease behaviour and treatment response in sarcoidosis trials.
Secukinumab in a patient with sarcoidosis.
Cardiac sarcoidosis: systematic review of the literature on corticosteroid and immunosuppressive therapies.
Outcomes of prednisone-tapering regimens for cardiac sarcoidosis: A retrospective analysis demonstrating a benefit of infliximab.